The completion of the funding round follows Newronika’s recent receival of an IDE from the FDA for the Parkinson’s therapy ...

Deep brain stimulation (DBS) has shown remarkable therapeutic benefits for patients with otherwise treatment-resistant movement and affective disorders, such as chronic pain, Parkinson's disease ...

Medicare covers deep brain stimulation (DBS) to treat Parkinson’s disease or essential tremor when a doctor deems it medically necessary and when a person meets the coverage criteria.

Unable to speak because of a brain disorder known as spasmodic dysphonia, Susan O'Sullivan signed up for a clinical trial, ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Parkinson's Disease Treatment Market Aging Populations and Advancements in Deep Brain Stimulation, Gene Therapy, and Medications Fuel Marke ...

Newronika, a global leader in advanced deep brain stimulation, is pleased to announce the successful closing of its €13.6 ...

Traditional deep brain stimulation surgery can take up to 10 hours to complete, with the patient wide awake. This robotic ...

Newronika SpA's AlphaDBS recently secured an investigational device exemption from the U.S. FDA allowing it to begin a pivotal trial to evaluate the safety and efficacy of its adaptive deep brain ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

Discover how MR-guided focused ultrasound offers a revolutionary non-invasive treatment for tremors and epilepsy reducing symptoms without surgery or implants ...